Search results
Nike upgraded, Palantir downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 10 hours agoTop Initiations: DA Davidson initiated coverage of Palo Alto Networks (PANW) with a Buy rating and...
Expert Ratings For Agios Pharmaceuticals - Agios Pharmaceuticals (NASDAQ:AGIO)
Benzinga· 4 days agoThe following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken & ...
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock ...
This New Stock With 95% Earnings Growth Eyes First Entry
Investor's Business Daily· 6 hours agoThe firm said it is using proceeds from the offering to "make capital contributions to its insurance...
Are Microcaps a Good Proxy for Private Equity?
Zacks via Yahoo Finance· 9 hours agoOr the private equity firm itself may use debt in combination with equity to fund investments. Investors may have specific opinions on economic...
Brokerages Set Kinross Gold Co. (NYSE:KGC) Target Price at $7.59
ETF DAILY NEWS· 2 days agoShares of Kinross Gold Co. (NYSE:KGC – Get Free Report) (TSE:K) have earned a consensus rating of “Moderate Buy” from the eight ratings firms that are currently ...
Wall Street Favorites: 3 Tech Stocks With Strong Buy Ratings for June 2024
InvestorPlace· 22 hours agoDespite recent market fluctuations, tech stocks remain strong long-term buys with the potential to...
Safeguard Financial LLC Takes $235,000 Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 8 hours ago(NYSE:ABBV – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 1,292 shares of the company’s stock ...
The Most Comfortable Couches You Can Buy at Amazon, According to Thousands of Reviews
People via Yahoo News· 13 hours agoAnother shopper said this couch is more on “the firm side," but in a supportive way, adding that...
Virios Therapeutics (NASDAQ:VIRI) Coverage Initiated by Analysts at Maxim Group
ETF DAILY NEWS· 20 hours agoMaxim Group started coverage on shares of Virios Therapeutics (NASDAQ:VIRI – Free Report) in a research report report published on Thursday morning, Benzinga reports. The firm
